A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)
Clinical trial NCT00427362 · COMPLETED
Trial details
- NCT number
- NCT00427362
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2007-05-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.